Brown University Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 146
• Ovarian cancer diagnosis and treatment 107
• Cervical Cancer and HPV Research 41
• PARP inhibition in cancer therapy 25
• Uterine Myomas and Treatments 23
• BRCA gene mutations in cancer 21
• Cancer survivorship and care 16
• Palliative Care and End-of-Life Issues 8
• Immune Cell Function and Interaction 7
• Breast Implant and Reconstruction 6
• Cancer Immunotherapy and Biomarkers 6
• Pelvic floor disorders treatments 6

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Ashley Stuckey

2. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Robert Giuntoli

3. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Cara Mathews

4. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Robert Giuntoli

5. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 420 citations · Paul DiSilvestro, Cara Mathews

6. Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.